Literature DB >> 21789894

Interference of the apoptotic signaling pathway in RGC stress response by SP600125 in moderate ocular hypertensive rats.

Hongxia Liu1, Hui Sun, Chuanyong Liu.   

Abstract

The aim of the present study was to investigate the effect of SP600125 (1,9-pyrazoloanthrone), an inhibitor of JNK, on apoptosis of retinal ganglion cells (RGCs) induced by moderate elevation of intraocular pressure (IOP) in male rats. IOP was elevated by suture-pulley compression on eyeballs. Cell apoptosis, expression of phosphorylated JNK (p-JNK) and cleaved caspase-3 in retina were studied by TUNEL staining and immunohistochemistry. The expression of c-Jun in retina was assayed by Western blot. Following IOP elevation (about 45 mmHg) for 6 h, the number of TUNEL, p-JNK and cleaved caspase-3 positive cells and the amount of c-Jun expression in retina were significantly increased. All these changes were reversed by SP600125 treatment. The immune positive cells for TUNEL, p-JNK and cleaved caspase-3 following IOP elevation were localized at the RGC layer. We conclude that moderate elevation of IOP for 6 h induced apoptosis of RGCs, and SP600125 treatment attenuated this process by suppressing c-Jun expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21789894

Source DB:  PubMed          Journal:  Chin J Physiol        ISSN: 0304-4920            Impact factor:   1.764


  10 in total

1.  Activation of TLR3 promotes the degeneration of retinal ganglion cells by upregulating the protein levels of JNK3.

Authors:  Shravan K Chintala; Nahrain Putris; Mason Geno
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-06       Impact factor: 4.799

Review 2.  BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells.

Authors:  Margaret E Maes; Cassandra L Schlamp; Robert W Nickells
Journal:  Prog Retin Eye Res       Date:  2017-01-04       Impact factor: 21.198

Review 3.  Targets of Neuroprotection in Glaucoma.

Authors:  Shaoqing He; Dorota L Stankowska; Dorette Z Ellis; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  J Ocul Pharmacol Ther       Date:  2017-08-18       Impact factor: 2.671

Review 4.  Axon injury signaling and compartmentalized injury response in glaucoma.

Authors:  Stephanie B Syc-Mazurek; Richard T Libby
Journal:  Prog Retin Eye Res       Date:  2019-07-10       Impact factor: 21.198

Review 5.  Discovery of novel inhibitors for the treatment of glaucoma.

Authors:  Kishore Cholkar; Hoang M Trinh; Dhananjay Pal; Ashim K Mitra
Journal:  Expert Opin Drug Discov       Date:  2015-01-09       Impact factor: 6.098

6.  JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death.

Authors:  Kimberly A Fernandes; Jeffrey M Harder; Laura B Fornarola; Robert S Freeman; Abbot F Clark; Iok-Hou Pang; Simon W M John; Richard T Libby
Journal:  Neurobiol Dis       Date:  2012-02-14       Impact factor: 5.996

7.  Impacts of Rho kinase inhibitor Fasudil on Rho/ROCK signaling pathway in rabbits with optic nerve injury.

Authors:  Jianglong Yu; Lin Lin; Xinping Luan; Xiepan Jing
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

8.  Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension.

Authors:  Hui Sun; Ying Wang; Iok-Hou Pang; Jiaquan Shen; Xia Tang; Ying Li; Chuanyong Liu; Bing Li
Journal:  Mol Vis       Date:  2011-04-06       Impact factor: 2.367

Review 9.  An introduction to DARC technology.

Authors:  Syed Shoeb Ahmad
Journal:  Saudi J Ophthalmol       Date:  2016-08-22

Review 10.  Caspases in retinal ganglion cell death and axon regeneration.

Authors:  Chloe N Thomas; Martin Berry; Ann Logan; Richard J Blanch; Zubair Ahmed
Journal:  Cell Death Discov       Date:  2017-07-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.